"Most science-driven companies don’t stall because the science is weak.
They stall because commercialization isn’t designed with the same rigor."
- A working excerpt from The Propel Commercial Acceleration Playbook™
Early validation exists, but momentum feels fragile
Sales progress depends too heavily on founders or senior leaders
Commercial decisions get revisited instead of executed
Activity is high, but compounding progress is inconsistent
• A working excerpt from the Commercial Acceleration Playbook™
• How commercialization is structured as an operational system
• Where momentum commonly degrades as companies scale
• Leaders of science-driven companies navigating commercialization
• Teams experiencing uneven or fragile growth
• Organizations under pressure to professionalize revenue
** If you’re looking for lead-gen tactics or marketing hacks, this won’t be useful.

propelbiosciences.com
Raleigh, NC